Role of bridging RT in relapsed/refractory diffuse large B-cell lymphoma undergoing CAR-T therapy: a multicenter study.

Autor: Bramanti S; IRCCS Humanitas Research Hospital, Humanitas, Cancer Center, Milano, Rozzano Milano, Italy., Mannina D; IRCCS Humanitas Research Hospital, Humanitas, Cancer Center, Milano, Rozzano Milano, Italy. daniele.mannina@humanitas.it., Chiappella A; IRCCS Istituto Nazionale Tumori, Milano, Italy., Casadei B; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy., De Philippis C; IRCCS Humanitas Research Hospital, Humanitas, Cancer Center, Milano, Rozzano Milano, Italy., Giordano L; IRCCS Humanitas Research Hospital, Humanitas, Cancer Center, Milano, Rozzano Milano, Italy., Navarria P; IRCCS Humanitas Research Hospital, Humanitas, Cancer Center, Milano, Rozzano Milano, Italy., Mancosu P; IRCCS Humanitas Research Hospital, Humanitas, Cancer Center, Milano, Rozzano Milano, Italy., Taurino D; IRCCS Humanitas Research Hospital, Humanitas, Cancer Center, Milano, Rozzano Milano, Italy., Scorsetti M; IRCCS Humanitas Research Hospital, Humanitas, Cancer Center, Milano, Rozzano Milano, Italy., Carlo-Stella C; IRCCS Humanitas Research Hospital, Humanitas, Cancer Center, Milano, Rozzano Milano, Italy., Zinzani P; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Scienze Mediche e Chirurgiche, Università di Bologna, Bologna, Italy., Santoro A; IRCCS Humanitas Research Hospital, Humanitas, Cancer Center, Milano, Rozzano Milano, Italy.; Dept. of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milano, Italy., Corradini P; IRCCS Istituto Nazionale Tumori, Milano, Italy.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2024 Oct 09. Date of Electronic Publication: 2024 Oct 09.

Allogeneic transplantation after immunotherapy for relapsed/refractory non-Hodgkin lymphoma: a comparison with a historical cohort.

Autor: Mariotti J; Department of Oncology/Hematology, Humanitas Research Hospital, Istituto di Ricovero e cura a carattere scientifico, Rozzano, Milan, Italy. Electronic address: jacopo.mariotti@humanitas.it., Zucchinetti C; Department of Oncology/Hematology, Humanitas Research Hospital, Istituto di Ricovero e cura a carattere scientifico, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Giordano L; Biostatistic Unit, Humanitas Research Hospital, Istituto di Ricovero e Cura a Carattere Scientifico, Rozzano, Milan, Italy., De Philippis C; Department of Oncology/Hematology, Humanitas Research Hospital, Istituto di Ricovero e cura a carattere scientifico, Rozzano, Milan, Italy., Mannina D; Department of Oncology/Hematology, Humanitas Research Hospital, Istituto di Ricovero e cura a carattere scientifico, Rozzano, Milan, Italy., Sarina B; Department of Oncology/Hematology, Humanitas Research Hospital, Istituto di Ricovero e cura a carattere scientifico, Rozzano, Milan, Italy., Taurino D; Department of Oncology/Hematology, Humanitas Research Hospital, Istituto di Ricovero e cura a carattere scientifico, Rozzano, Milan, Italy., Carbon R; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Santoro A; Department of Oncology/Hematology, Humanitas Research Hospital, Istituto di Ricovero e cura a carattere scientifico, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Bramanti S; Department of Oncology/Hematology, Humanitas Research Hospital, Istituto di Ricovero e cura a carattere scientifico, Rozzano, Milan, Italy.

Publikováno v: Cytotherapy [Cytotherapy] 2024 Oct; Vol. 26 (10), pp. 1163-1169. Date of Electronic Publication: 2024 May 05.

End of induction [ ¹⁸ F]FDG PET is prognostic for progression-free survival and overall survival in follicular lymphoma patients enrolled in the FOLL12 trial.

Autor: Guerra L; Nuclear Medicine, Fondazione IRCCS San Gerardo Dei Tintori, Monza, Italy. luca.guerra@unimib.it.; University of Milano Bicocca, Milan, Italy. luca.guerra@unimib.it., Chauvie S; Medical Physics, Ospedale Santa Croce E Carle, Cuneo, Italy., Fallanca F; Nuclear Medicine, IRCCS Ospedale San Raffaele, Milan, Italy., Bergesio F; Medical Physics, Ospedale Santa Croce E Carle, Cuneo, Italy., Marcheselli L; Fondazione Italiana Linfomi, Modena, Italy., Durmo R; Nuclear Medicine, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Peano S; Nuclear Medicine Azienda Ospedaliera S. Croce E Carle, Cuneo, Italy., Franceschetto A; Nuclear Medicine, Azienda Ospedaliero-Universitaria Di Modena, Modena, Italy., Monaco L; Nuclear Medicine, Fondazione IRCCS San Gerardo Dei Tintori, Monza, Italy., Barbieri E; Clinical and Experimental Medicine PhD Program, University of Modena E Reggio Emilia, Modena, Italy., Ladetto M; Hematology Unit, Azienda Ospedaliera Di Alessandria, Alessandria, Italy., Musuraca G; Hematology and HSC Transplantation, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori, Meldola, Italy., Tosi P; Hematology Unit, AUSL Della Romagna, Rimini, Italy., Bianchi B; Hematology Unit, Ospedale Di Circolo E Fondazione Macchi ASST Sette Laghi, Varese, Italy., Bolis SAM; Hematology Unit, Fondazione IRCCS San Gerardo Dei Tintori, Monza, Italy., Pavone V; Hematology and Bone Marrow Transplantation, Ospedale C. Panico, Tricase, Italy., Chiarenza A; Hematology and Bone Marrow Transplantation, AOU Policlinico S. Marco, Catania, Italy., Arcari A; Hematology Unit, Ospedale Guglielmo da Saliceto, Piacenza, Italy., Califano C; Hematology Unit, Ospedale Andrea Tortora, Pagani, Italy., Bari A; Oncology Unit, Azienda Ospedaliero-Universitaria Policlinico, Modena, University of Modena and Reggio Emilia, Modena, Italy., Massaia M; Hematology Unit, Ospedale Santa Croce E Carle, Cuneo, Italy., Conconi A; Hematology Unit, Ospedale Degli Infermi, Biella, Italy., Musto P; Hematology and Stem Cells Transplantation, IRCCS CROB, Rionero in Vulture, Italy., Mannina D; Hematology Unit, Azienda Ospedaliera Papardo, Messina, Italy., Roti G; Hematology Unit, Azienda Ospedaliero-Universitaria Di Parma, Parma, Italy., Galimberti S; Hematology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy., Gini G; Hematology Unit, Azienda Ospedaliero-Universitaria Delle Marche, Ancona, Italy., Falcinelli F; Hematology and Bone Marrow Transplantation, Azienda Ospedaliera Di Perugia, Perugia, Italy., Vitolo U; Hematology Unit, Candiolo Cancer Institute, FPO-IRCCS, Candiolo, Italy., Usai SV; Hematology and Bone Marrow Transplantation, Ospedale Brotzu, Cagliari, Italy., Stefani PM; Hematology Unit, General Hospital Ca' Foncello, Treviso, Italy., Ibatici A; Ematologia E Terapie Cellulari, IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Liberati AM; Università Degli Studi Di Perugia, A.O. Terni, Terni, Italy., Pennese E; Hematology Unit, ASL Pescara, Pescara, Italy., Perrone T; Hematology and Stem Cells Transplantation, AOUC Policlinico, Bari, Italy., Versari A; Nuclear Medicine, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy., Luminari S; Hematology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.; Department Chimomo, Università Di Modena and Reggio Emilia, Modena, Italy.

Publikováno v: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Sep; Vol. 51 (11), pp. 3311-3321. Date of Electronic Publication: 2024 May 25.

Correction to: Primary vs. pre-emptive anti-seizure medication prophylaxis in anti-CD19 CAR T-cell therapy.

Autor: Pensato U; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy. umbertopensato91@gmail.com.; IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy. umbertopensato91@gmail.com., Pondrelli F; Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.; IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy., de Philippis C; BMT and Cell Therapy Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Asioli GM; Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.; IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy., Crespi A; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.; IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy., Buizza A; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy.; IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy., Mannina D; BMT and Cell Therapy Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Casadei B; IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Istituto Di Ematologia 'Seràgnoli', Bologna, Italy., Maffini E; IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Istituto Di Ematologia 'Seràgnoli', Bologna, Italy., Straffi L; IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy., Marcheselli S; IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089, Rozzano, Milan, Italy., Zinzani PL; IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Istituto Di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento Di Scienze Mediche E Chirurgiche, Università Di Bologna, Bologna, Italy., Bonifazi F; IRCCS Azienda Ospedaliero-Universitaria Di Bologna, Istituto Di Ematologia 'Seràgnoli', Bologna, Italy., Guarino M; IRCCS Istituto Delle Scienze Neurologiche Di Bologna, Bologna, Italy., Bramanti S; BMT and Cell Therapy Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

Publikováno v: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology [Neurol Sci] 2024 Aug; Vol. 45 (8), pp. 4107.

Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial.

Autor: Pulsoni A; Hematology, Department of Translational and Precision Medicine, Sapienza University-Polo Pontino, S.M. Goretti Hospital, Latina, Italy. Electronic address: alessandro.pulsoni@uniroma1.it., Ferrero S; Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Torino/AOU 'Città della Salute e della Scienza di Torino', Turin, Italy., Tosti ME; Istituto Superiore di Sanità, National Center for Global Health, Rome, Italy., Luminari S; Hematology Unit, Arcispedale S Maria Nuova, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy; Department CHIMOMO, University of Modena and Reggio Emilia, Reggio Emilia, Italy., Dondi A; Fondazione Italiana Linfomi Onlus (FIL), Modena, Italy., Cavallo F; Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Torino/AOU 'Città della Salute e della Scienza di Torino', Turin, Italy., Merli F; Hematology Unit, Arcispedale S Maria Nuova, Azienda Unità Sanitaria Locale-IRCCS, Reggio Emilia, Italy., Liberati AM; AO Santa Maria Terni, University of Perugia, Perugia, Italy., Cenfra N; Hematology Unit, S Maria Goretti Hospital, AUSL Latina, Latina, Italy., Renzi D; Hematology and Stem Cells Transplantation Unit, IRCCS Istituto Nazionale dei Tumori Regina Elena, Rome, Italy., Zanni M; Division of Hematology, SS Antonio e Biagio Hospital, Alessandria, Italy., Boccomini C; SC Hematology, AOU Città della Salute e della Scienza, Turin, Italy., Ferreri AJM; Lymphoma Unit, IRCCS San Raffaele Scientific Institute, University Vita-Salute San Raffaele, Milan, Italy., Rattotti S; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy., Zilioli VR; Division of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Bolis SA; Struttura Complessa di Ematologia, Fondazione IRCCS San Gerardo dei Tintori-Monza, Monza, Italy., Bernuzzi P; Hematology Unit, Department of Onco-Hematology, Guglielmo da Saliceto Hospital, Piacenza, Italy., Musuraca G; Hematology Unit, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Gaidano G; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy., Perrone T; Unit of Hematology with Transplantation, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy., Stelitano C; Department of Hematology, Azienda Ospedaliera Bianchi Melacrinò Morelli, Reggio Calabria, Italy., Tucci A; Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Corradini P; Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy., Bigliardi S; Onco-Hematology Department, Nuovo Ospedale Civile di Sassuolo, Sassuolo, Italy., Re F; Hematology Clinic, AOU di Parma, Parma, Italy., Cencini E; Unit of Hematology, Azienda Ospedaliera Universitaria Senese and University of Siena, Siena, Italy., Mannarella C; Hematology Unit, 'Madonna delle Grazie' Hospital, Matera, Italy., Mannina D; Department of Hematology, Azienda Ospedaliera Papardo, Messina, Italy., Celli M; Hematology, Ospedale degli Infermi, Rimini, Italy., Tani M; Hematology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy., Annechini G; Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Assanto GM; Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Grapulin L; Department of Radiotherapy, AOU Policlinico Umberto I, Rome, Italy., Guarini A; Hematology, Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy., Cavalli M; Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., De Novi LA; Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Bomben R; Clinical and Experimental Onco-Hematology Unit, CRO Aviano National Cancer Institute, Aviano, Italy., Ciabatti E; Section of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Genuardi E; Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Torino/AOU 'Città della Salute e della Scienza di Torino', Turin, Italy., Drandi D; Hematology Division, Department of Molecular Biotechnologies and Health Sciences, University of Torino/AOU 'Città della Salute e della Scienza di Torino', Turin, Italy., Della Starza I; Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy; AIL Roma, ODV, Rome, Italy., Arcaini L; Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Molecular Medicine, University of Pavia, Pavia, Italy., Ricardi U; Radiation Oncology, Department of Oncology, University of Turin, Turin, Italy., Gattei V; Clinical and Experimental Onco-Hematology Unit, CRO Aviano National Cancer Institute, Aviano, Italy., Galimberti S; Section of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Ladetto M; Department of Translational Medicine, SCDU Ematologia AO SS Antonio e Biagio E Cesare Arrigo, Università del Piemonte Orientale, Alessandria, Italy., Foà R; Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy., Del Giudice I; Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. Electronic address: ilaria.delgiudice@uniroma1.it.

Publikováno v: The Lancet. Haematology [Lancet Haematol] 2024 Jul; Vol. 11 (7), pp. e499-e509.